Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils.
Articles
Global Payout, Inc. (GOHE) Enters Final Stages of Audit in Preparation for Uplisting to OTCQB Venture Marketplace
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company.
Global Payout, Inc. (GOHE) Subsidiary Teams with Pegasus Fintech, Inc. to Develop Cryptocurrency-Based Token
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has established a strategic partnership with Pegasus Fintech, Inc.
Maricann Provides Update on Financing, NanoLeaf Acquisition and Other Matters
Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) announces that insiders of the Company have agreed to purchase $7,000,000 of convertible debenture units (the "Convertible Debenture Units") in its previously announced private placement offering.
What Can Canada Learn from the US When it Comes to Cannabis Legalization?
From underage access to taxes and enforcement costs, Canada’s swimming in concerns around the impending legalization of cannabis. Drawing on data from the US’s legal-cannabis states, Leafly addresses each of Canada’s fears by addressing how each has played out south of the border.
The post What Can Canada Learn from the US When it Comes to Cannabis Legalization? appeared first on Leafly.
Cronos Group Inc. Announces $15 Million Bought Deal
Cronos Group Inc. (TSX VENTURE: MJN) is pleased to announce that it has entered into a letter of engagement with PI Financial Corp. ("PI") as sole lead underwriter.
Marapharm Ventures Inc. Announces that it has Purchased an Additional 1.5 Million Units of Veritas Pharma Inc.
Marapharm announced today that it has purchased 1,500,000 units of Veritas Pharma Inc. at a purchase price of $0.28 per unit
FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) Announce Profit Sharing Agreement with Cultivation Technologies, Inc.
FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) this morning announced that FinCanna will share 50 percent of the profits from Cultivation Technologies’ interim medical cannabis extraction facility operating in Coachella, California.
Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
EVIO, Inc. (EVIO) Expands Testing Capabilities at Yuba City Laboratory
EVIO, Inc. this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California.
Medical Marijuana, Inc. Announces Robert ’Bo’ Brannin as Senior Director of Operations for Subsidiary Kannaway
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that its subsidiary Kannaway® LLC is welcoming Robert "Bo" Brannin as its new Senior Director of Operations.
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided compelling in vitro data
SinglePoint, Inc. (SING) CEO Featured in Equities.com Interview
SinglePoint (OTC: SING) was featured in an article published by Equities.com in which the company’s chief executive officer, Greg Lambrecht, was interviewed.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.